Modelling the economic impact of substandard and falsified medicines: the case of antimalarials in the democratic republic of congo

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-HMIS-021
• By: OZAWA, Sachiko (University of North Carolina at Chapel Hill, Practice Advancement and Clinical Education, Chapel Hill, United States)
• Co-author(s): Sachiko Ozawa: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
  Sophia Bessias: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
  Deson Haynie: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
  Tatenda Yemeke: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
  
• Abstract:

  Background

  Access to high-quality medicines is a critical element in reaching the Sustainable Development Goals (SDGs). Substandard and falsified medicines pose significant risks to global health, including increased deaths, prolonged treatment times and increased drug resistance. Antimalarial drugs, despite their importance in global health, are..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login